Citigroup
EDSA icon

Citigroup’s Edesa Biotech EDSA Stock Holding History

Citigroup’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.55K Buy
+487
New +$1.46K ﹤0.01% 5395
2025
Q4 		– Sell
-2,000
Closed -$4.88K – 6153
2025
Q3 		$4.88K Buy
+2,000
New +$4.63K ﹤0.01% 5238
2024
Q1 		– Sell
-2
Closed -$9 – 5691
2023
Q4 		$9 Buy
+2
New +$8 ﹤0.01% 5639
2016
Q2 		– Sell
-2
Closed -$3K – 7145
2016
Q1 		$3K Buy
+2
New +$3.5K ﹤0.01% 7126

Other funds holding EDSA

VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return

Citigroup's EDSA Position: Q1 2026 in Review

Citigroup opened a new position in Edesa Biotech (EDSA) in Q1 2026: 487 shares worth $2.55K. The stake represents ﹤0.01% of the portfolio and ranks #5395 among its holdings. This is a return to the name: Citigroup previously reported a position in EDSA as recently as Q3 2025.

Citigroup first reported a position in EDSA in Q1 2016 and has held it in 4 quarters since. The position peaked at $4.88K in Q3 2025. 28 funds tracked by Wall St. Rank hold EDSA as of Q1 2026.

  • Citigroup held 487 shares of Edesa Biotech worth $2.55K as of Q1 2026.
  • Edesa Biotech was a new Citigroup position in Q1 2026.
  • Edesa Biotech made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5395 holding.
  • Citigroup first reported a position in Edesa Biotech in Q1 2016 and has held it in 4 quarters since.
  • Citigroup's Edesa Biotech position peaked at $4.88K in Q3 2025.
  • 28 funds tracked by Wall St. Rank held Edesa Biotech as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.